Literature DB >> 1137832

Use of high-dosage trimethoprim-sulfamethoxazole in sinusitis.

E Whitehead.   

Abstract

The combination trimethoprim-sulfamethoxazole was given in high dosage (four tablets twice daily) for either 2 or 5 days to 20 patients with sinusitis diagnosed on clinical grounds. In 11 the infection was improved or cured. Swabs cultured from 18 patients of the series produced no growth in 8. The organisms most likely to be isolated are Hemophilus influenzae and Diplococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137832      PMCID: PMC1956437     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

1.  THE BACTERIAL FLORA OF SINUSITIS WITH AN IN VITRO STUDY OF THE BACTERIAL RESISTANCE TO ANTIBIOTICS.

Authors:  A LYSTAD; P BERDAL; L LUND-IVERSEN
Journal:  Acta Otolaryngol Suppl       Date:  1964

2.  Complicated acute sinusitis.

Authors:  C A Quick; E Payne
Journal:  Laryngoscope       Date:  1972-07       Impact factor: 3.325

3.  Effects in man of prolonged administration of trimethoprim and sulfisoxazole.

Authors:  E N Whitman
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

4.  A combination of trimethoprim and sulphamethoxazole in upper respiratory infection.

Authors:  B W McGuinness
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

5.  Various regimens of trimethoprim-sulfamethoxazole used in the treatment of gonorrhea.

Authors:  A Lawrence; I Phillips; C Nicol
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

6.  Trimethoprim-sulfamethoxazole in the treatment of infections of the ears, nose, and throat.

Authors:  C A Quick; D Wagner
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

7.  The correlation between bacteriological findings in the nose and maxillary sinus in acute maxillary sinusitis.

Authors:  A Axelsson; J E Brorson
Journal:  Laryngoscope       Date:  1973-12       Impact factor: 3.325

  7 in total
  1 in total

Review 1.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.